Robert Hauser

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Anatomy

Corpus Striatum

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Tanner Caroline M; Ross G Webster; Jewell Sarah A; Hauser Robert A; Jankovic Joseph; Factor Stewart A; Bressman Susan; Deligtisch Amanda; Marras Connie; Lyons Kelly E; Bhudhikanok Grace S; Roucoux Diana F; Meng Cheryl; Abbott Robert D; Langston J William
Occupation and risk of parkinsonism: a multicenter case-control study.
Cicchetti F; Saporta S; Hauser R A; Parent M; Saint-Pierre M; Sanberg P R; Li X J; Parker J R; Chu Y; Mufson E J; Kordower J H; Freeman T B
Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration.
Seeberger Lauren C; Hauser Robert A
Levodopa/carbidopa/entacapone in Parkinson's disease.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Robert Hauser (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Tanner Caroline M; Ross G Webster; Jewell Sarah A; Hauser Robert A; Jankovic Joseph; Factor Stewart A; Bressman Susan; Deligtisch Amanda; Marras Connie; Lyons Kelly E; Bhudhikanok Grace S; Roucoux Diana F; Meng Cheryl; Abbott Robert D; Langston J William
Occupation and risk of parkinsonism: a multicenter case-control study.
Archives of neurology 2009;66(9):1106-13.
2009: Cicchetti F; Saporta S; Hauser R A; Parent M; Saint-Pierre M; Sanberg P R; Li X J; Parker J R; Chu Y; Mufson E J; Kordower J H; Freeman T B
Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(30):12483-8.
2009: Seeberger Lauren C; Hauser Robert A
Levodopa/carbidopa/entacapone in Parkinson's disease.
Expert review of neurotherapeutics 2009;9(7):929-40.
2009: Connors John J; Sacks David; Furlan Anthony J; Selman Warren R; Russell Eric J; Stieg Philip E; Hadley Mark N; Wojak Joan C; Koroshetz Walter J; Heros Roberto C; Strother Charles M; Duckwiler Gary R; Durham Janette D; Tom-sick Thomas O; Rosenwasser Robert H; McDougall Cameron G; Haughton Victor M; Derdeyn Colin P; Wechsler Lawrence R; Hudgins Patricia A; Alberts Mark J; Raabe Rodney D; Gomez Camillo R; Cawley C Michael; Krol Katharine L; Futrell Nancy; Hauser Robert A; Frank Jeffrey I
Training, competency, and credentialing standards for diagnostic cervicocerebral angiography, carotid stenting, and cerebrovascular intervention: a joint statement from the American Academy of Neurology, the American Association of Neurological Surgeons, the American Society of Interventional and Therapeutic Neuroradiology, the American Society of Neuroradiology, the Congress of Neurological Surgeons, the AANS/CNS Cerebrovascular Section, and the Society of Interventional Radiology.
Journal of vascular and interventional radiology : JVIR 2009;20(7 Suppl):S292-301.
2009: Jenner P; Mori A; Hauser R; Morelli M; Fredholm B B; Chen J F
Adenosine, adenosine A 2A antagonists, and Parkinson's disease.
Parkinsonism & related disorders 2009;15(6):406-13.
2009: Hauser Robert A; Lyons Kelly E; McClain Terry; Carter Summer; Perlmutter David
Randomized, double-blind, pilot evaluation of intravenous glutathione in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2009;24(7):979-83.
2009: Hauser Robert A; Lew Mark F; Hurtig Howard I; Ondo William G; Wojcieszek Joanne; Fitzer-Attas Cheryl J;
Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2009;24(4):564-73.
2009: Hauser Robert A; Panisset Michel; Abbruzzese Giovanni; Mancione Linda; Dronamraju Nalina; Kakarieka Algirdas;
Double-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2009;24(4):541-50.
2009: Zesiewicz Theresa A; Hauser Robert A; Freeman Alan; Sullivan Kelly L; Miller Amber M; Halim Tariq
Fentanyl-induced bradykinesia and rigidity after deep brain stimulation in a patient with Parkinson disease.
Clinical neuropharmacology 2009;32(1):48-50.
2009: Hauser R A; Bronzova J; Sampaio C; Lang A E; Rascol O; Theeuwes A; van de Witte S V;
Safety and tolerability of pardoprunox, a new partial dopamine agonist, in a randomized, controlled study of patients with advanced Parkinson's disease.
European neurology 2009;62(1):40-8.
2009: Hauser Robert A
Levodopa: past, present, and future.
European neurology 2009;62(1):1-8.
2009: Simuni Tanya; Lyons Kelly E; Pahwa Rajesh; Hauser Robert A; Comella Cynthia; Elmer Lawrence; Weintraub Daniel
Treatment of early Parkinson's disease. Part 2.
European neurology 2009;61(4):206-15.
2009: Simuni Tanya; Lyons Kelly E; Pahwa Rajesh; Hauser Robert A; Comella Cynthia; Elmer Lawrence; Weintraub Daniel
Treatment of early Parkinson's disease. Part 1.
European neurology 2009;61(4):193-205.
2008: Kordower Jeffrey H; Chu Yaping; Hauser Robert A; Olanow C Warren; Freeman Thomas B
Transplanted dopaminergic neurons develop PD pathologic changes: a second case report.
Movement disorders : official journal of the Movement Disorder Society 2008;23(16):2303-6.
2008: Olanow C Warren; Hauser Robert A; Jankovic Joseph; Langston William; Lang Anthony; Poewe Werner; Tolosa Eduardo; Stocchi Fabrizio; Melamed Eldad; Eyal Eli; Rascol Olivier
A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): rationale, design, and baseline characteristics.
Movement disorders : official journal of the Movement Disorder Society 2008;23(15):2194-201.
2008: Hauser Robert A; Shulman Lisa M; Trugman Joel M; Roberts John W; Mori Akihisa; Ballerini Rocco; Sussman Neil M;
Study of istradefylline in patients with Parkinson's disease on levodopa with motor fluctuations.
Movement disorders : official journal of the Movement Disorder Society 2008;23(15):2177-85.
2008: Shimberg W Reed; Patel Neha B; Sullivan Kelly L; Hauser Robert A; Zesiewicz Theresa A
Levetiracetam for stiff-person syndrome: report of 2 patients.
Clinical neuropharmacology 2008;31(5):301-2.
2008: Simon David K; Swearingen Christopher J; Hauser Robert A; Trugman Joel M; Aminoff Michael J; Singer Carlos; Truong Daniel; Tilley Barbara C;
Caffeine and progression of Parkinson disease.
Clinical neuropharmacology 2008;31(4):189-96.
2008: Kordower Jeffrey H; Chu Yaping; Hauser Robert A; Freeman Thomas B; Olanow C Warren
Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease.
Nature medicine 2008;14(5):504-6.
2008: Goetz Christopher G; Wuu Joanne; McDermott Michael P; Adler Charles H; Fahn Stanley; Freed Curt R; Hauser Robert A; Olanow Warren C; Shoulson Ira; Tandon P K; Leurgans Sue
Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventions.
Movement disorders : official journal of the Movement Disorder Society 2008;23(5):690-9.
2008: Zesiewicz Theresa A; Shimberg W Reed; Hauser Robert A; Robinson Wendy; Wilson Maria-Carmen; Sullivan Kelly L
Chorea as a side effect of gabapentin (Neurontin) in a patient with complex regional pain syndrome Type 1.
Clinical rheumatology 2008;27(3):389-90.
2008: Encarnacion Elmyra V; Hauser Robert A
Levodopa-induced dyskinesias in Parkinson's disease: etiology, impact on quality of life, and treatments.
European neurology 2008;60(2):57-66.
2008: Zesiewicz Theresa A; Sullivan Kelly L; Hoffmann Michael; Benes Lourdes M; Smith Donald A; Ward Christopher L; Hauser Robert A
Delayed thalamic intracranial hemorrhage in an essential tremor patient following deep brain stimulation.
European neurology 2008;59(3-4):187-9.
2007: Seeberger Lauren C; Hauser Robert A
Optimizing bioavailability in the treatment of Parkinson's disease.
Neuropharmacology 2007;53(7):791-800.
2007: Hauser Robert A; Rascol Olivier; Korczyn Amos D; Jon Stoessl A; Watts Ray L; Poewe Werner; De Deyn Peter P; Lang Anthony E
Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa.
Movement disorders : official journal of the Movement Disorder Society 2007;22(16):2409-17.
2007: Zesiewicz T A; Patel-Larson A; Hauser R A; Sullivan K L
Social Security Disability Insurance (SSDI) in Parkinson's disease.
Disability and rehabilitation 2007;29(24):1934-6.
2007: Sullivan Kelly L; Ward Christopher L; Hauser Robert A; Zesiewicz Theresa A
Prevalence and treatment of non-motor symptoms in Parkinson's disease.
Parkinsonism & related disorders 2007;13(8):545.
2007: Simonson William; Hauser Robert A; Schapira Anthony H V
Role of the pharmacist in the effective management of wearing-off in Parkinson's disease.
The Annals of pharmacotherapy 2007;41(11):1842-9.
2007: Zesiewicz Theresa A; Sullivan Kelly L; Ward Christopher L; Hauser Robert A
Tiagabine and exacerbation of essential tremor.
Movement disorders : official journal of the Movement Disorder Society 2007;22(14):2132-3.
2007: Zesiewicz Theresa A; Ward Christopher L; Hauser Robert A; Salemi Jason L; Siraj Shaila; Wilson Maria-Carmen; Sullivan Kelly L
A pilot, double-blind, placebo-controlled trial of pregabalin (Lyrica) in the treatment of essential tremor.
Movement disorders : official journal of the Movement Disorder Society 2007;22(11):1660-3.
2007: Zesiewicz Theresa A; Sullivan Kelly L; Hauser Robert A
Levodopa-induced dyskinesia in Parkinson's disease: epidemiology, etiology, and treatment.
Current neurology and neuroscience reports 2007;7(4):302-10.
2007: Hauser Robert A; Zesiewicz Theresa A
Advances in the pharmacologic management of early Parkinson disease.
The neurologist 2007;13(3):126-32.
2007: Samanta Johan; Hauser Robert A
Duodenal levodopa infusion for the treatment of Parkinson's disease.
Expert opinion on pharmacotherapy 2007;8(5):657-64.
2007: Taylor Julie P; Hulihan Mary M; Kachergus Jennifer M; Melrose Heather L; Lincoln Sarah J; Hinkle Kelly M; Stone Jeremy T; Ross Owen A; Hauser Robert; Aasly Jan; Gasser Thomas; Payami Haydeh; Wszolek Zbigniew K; Farrer Matthew J
Leucine-rich repeat kinase 1: a paralog of LRRK2 and a candidate gene for Parkinson's disease.
Neurogenetics 2007;8(2):95-102.
2007: Hauser Robert A; Salin Laurence; Juhel Nolwenn; Konyago Victor L
Randomized trial of the triple monoamine reuptake inhibitor NS 2330 (tesofensine) in early Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2007;22(3):359-65.
2007: Stacy M; Hauser R
Development of a Patient Questionnaire to facilitate recognition of motor and non-motor wearing-off in Parkinson's disease.
Journal of neural transmission (Vienna, Austria : 1996) 2007;114(2):211-7.
2007: Zesiewicz Theresa A; Ward Christopher L; Hauser Robert A; Sanchez-Ramos Juan; Staffetti Joseph F; Sullivan Kelly L
A double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of essential tremor.
Movement disorders : official journal of the Movement Disorder Society 2007;22(2):279-82.
2007: Zesiewicz Theresa A; Ward Christopher L; Hauser Robert A; Pease Campbell Jessica A; Sullivan Kelly L
Pregabalin (Lyrica) in the treatment of essential tremor.
Movement disorders : official journal of the Movement Disorder Society 2007;22(1):139-41.
2006: Zesiewicz Theresa A; Sullivan Kelly L; Hauser Robert A
Nonmotor symptoms of Parkinson's disease.
Expert review of neurotherapeutics 2006;6(12):1811-22.
2006: Hauser Robert A; McDermott Michael P; Messing Susan
Factors associated with the development of motor fluctuations and dyskinesias in Parkinson disease.
Archives of neurology 2006;63(12):1756-60.
2006: Hauser Robert A; Russ Hermann; Haeger Doris-Anita; Bruguiere-Fontenille Michel; Müller Thomas; Wenning Gregor K
Patient evaluation of a home diary to assess duration and severity of dyskinesia in Parkinson disease.
Clinical neuropharmacology 2006;29(6):322-30.
2006: Stacy Mark; Hauser Robert; Oertel Wolfgang; Schapira Anthony; Sethi Kapil; Stocchi Fabrizio; Tolosa Eduardo
End-of-dose wearing off in Parkinson disease: a 9-question survey assessment.
Clinical neuropharmacology 2006;29(6):312-21.
2006: Zesiewicz Theresa A; Sullivan Kelly L; Hauser Robert A; Sanchez-Ramos Juan
Open-label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington's disease.
Movement disorders : official journal of the Movement Disorder Society 2006;21(11):1998-2001.
2006: Hauser Robert A
Long-term care of Parkinson's disease. Strategies for managing "wearing off" symptom re-emergence and dyskinesias.
Geriatrics 2006;61(9):14-20.
2006: Graff-Radford John; Foote Kelly D; Rodriguez Ramon L; Fernandez Hubert H; Hauser Robert A; Sudhyadhom Atchar; Rosado Christian A; Sanchez Justin C; Okun Michael S
Deep brain stimulation of the internal segment of the globus pallidus in delayed runaway dyskinesia.
Archives of neurology 2006;63(8):1181-4.
2006: Wolfrath Summer C; Borenstein Amy R; Schwartz Skai; Hauser Robert A; Sullivan Kelly L; Zesiewicz Theresa A
Use of nutritional supplements in Parkinson's disease patients.
Movement disorders : official journal of the Movement Disorder Society 2006;21(8):1098-101.
2006: Zesiewicz Theresa A; Tullidge Archer; Tidwell Jonathan; Sullivan Kelly L; Hauser Robert A
Topiramate-induced psychosis in patients with essential tremor: report of 2 cases.
Clinical neuropharmacology 2006;29(3):168-9.
2006: Zesiewicz Theresa A; Wecker Lynn; Sullivan Kelly L; Merlin Lisa R; Hauser Robert A
The controversy concerning plasma homocysteine in Parkinson disease patients treated with levodopa alone or with entacapone: effects of vitamin status.
Clinical neuropharmacology 2006;29(3):106-11.
2006: Hauser Robert A; Zesiewicz Theresa A
Clinical trials aimed at detecting neuroprotection in Parkinson's disease.
Neurology 2006;66(10 Suppl 4):S58-68.
2006: Zesiewicz Theresa A; Sullivan Kelly L; Hauser Robert A
Chorea induced by lamotrigine.
Journal of child neurology 2006;21(4):357; author reply 357-8.
2006: Pahwa Rajesh; Lyons Kelly E; Wilkinson Steven B; Simpson Richard K; Ondo William G; Tarsy Daniel; Norregaard Thorkild; Hubble Jean P; Smith Donald A; Hauser Robert A; Jankovic Joseph
Long-term evaluation of deep brain stimulation of the thalamus.
Journal of neurosurgery 2006;104(4):506-12.
2006: Zesiewicz Theresa A; Sullivan Kelly L; Hauser Robert A
Vascular hemichorea/hemiballismus and topiramate.
Movement disorders : official journal of the Movement Disorder Society 2006;21(4):581; author reply 582.
2006: Zesiewicz Theresa A; Pathak Amit; Sullivan Kelly L; Shamayev Mikhail; Hauser Robert A
Treatment of chorea with levetiracetam.
European journal of clinical pharmacology 2006;62(1):87.
2006: Sullivan Kelly L; Staffetti Joseph F; Hauser Robert A; Dunne Peter B; Zesiewicz Theresa A
Tegaserod (Zelnorm) for the treatment of constipation in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2006;21(1):115-6.
2005: Sullivan Kelly L; Hauser Robert A; Louis Elan D; Chari Ganesh; Zesiewicz Theresa A
Levetiracetam for the treatment of generalized dystonia.
Parkinsonism & related disorders 2005;11(7):469-71.
2005: Zesiewicz Theresa A; Sullivan Kelly L; Maldonado John L; Tatum William O; Hauser Robert A
Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2005;20(9):1205-9.
2005: Furtado Sarah; Sossi Vesna; Hauser Roberta A; Samii Ali; Schulzer Michael; Murphy Colleen B; Freeman Thomas B; Stoessl A Jon
Positron emission tomography after fetal transplantation in Huntington's disease.
Annals of neurology 2005;58(2):331-7.
2005: Zesiewicz Theresa A; Sanchez-Ramos Juan; Sullivan Kelly L; Hauser Robert A
Levetiracetam-induced parkinsonism in a Huntington disease patient.
Clinical neuropharmacology 2005;28(4):188-90.
2005: Truong Daniel; Duane Drake D; Jankovic Joseph; Singer Carlos; Seeberger Lauren C; Comella Cynthia L; Lew Mark F; Rodnitzky Robert L; Danisi Fabio O; Sutton James P; Charles P David; Hauser Robert A; Sheean Geoffrey L
Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study.
Movement disorders : official journal of the Movement Disorder Society 2005;20(7):783-91.
2005: Zesiewicz T A; Elble R; Louis E D; Hauser R A; Sullivan K L; Dewey R B; Ondo W G; Gronseth G S; Weiner W J;
Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology.
Neurology 2005;64(12):2008-20.
2005: Recio Maria V; Hauser Robert A; Louis Elan D; Radhashakar Harsha; Sullivan Kelly L; Zesiewicz Theresa A
Chorea in a patient with cerebral palsy: treatment with levetiracetam.
Movement disorders : official journal of the Movement Disorder Society 2005;20(6):762-4.
2005: Stacy Mark; Bowron Annette; Guttman Mark; Hauser Robert; Hughes Kim; Larsen Jan Petter; LeWitt Peter; Oertel Wolfgang; Quinn Niall; Sethi Kapil; Stocchi Fabrizio
Identification of motor and nonmotor wearing-off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessment.
Movement disorders : official journal of the Movement Disorder Society 2005;20(6):726-33.
2005: Sullivan Kelly L; Hauser Robert A; Zesiewicz Theresa A
Levetiracetam for the treatment of essential tremor.
Movement disorders : official journal of the Movement Disorder Society 2005;20(5):640.
2005: Connors John J; Sacks David; Furlan Anthony J; Selman Warren R; Russell Eric J; Stieg Philip E; Hadley Mark N; Wojak Joan C; Koroshetz Walter J; Heros Roberto C; Strother Charles M; Duckwiler Gary R; Durham Janette D; Tomsick Thomas O; Rosenwasser Robert H; McDougall Cameron G; Haughton Victor M; Derdeyn Colin P; Wechsler Lawrence R; Hudgins Patricia A; Alberts Mark J; Raabe Rodney D; Gomez Camillo R; Cawley C Michael; Krol Katharine L; Futrell Nancy; Hauser Robert A; Frank Jeffrey I;
Training, competency, and credentialing standards for diagnostic cervicocerebral angiography, carotid stenting, and cerebrovascular intervention: a joint statement from the American Academy of Neurology, the American Association of Neurological Surgeons, the American Society of Interventional and Therapeutic Neuroradiology, the American Society of Neuroradiology, the Congress of Neurological Surgeons, the AANS/CNS Cerebrovascular Section, and the Society of Interventional Radiology.
Neurology 2005;64(2):190-8.
2005: Hauser Robert A; Schwarzschild Michael A
Adenosine A2A receptor antagonists for Parkinson's disease: rationale, therapeutic potential and clinical experience.
Drugs & aging 2005;22(6):471-82.
2004: Zesiewicz Theresa A; Louis Elan D; Sullivan Kelly L; Menkin Martin; Dunne Peter B; Hauser Robert A
Substantial improvement in a Meige's syndrome patient with levetiracetam treatment.
Movement disorders : official journal of the Movement Disorder Society 2004;19(12):1518-21.
2004: Hauser Robert A; Deckers Frieda; Lehert Philippe
Parkinson's disease home diary: further validation and implications for clinical trials.
Movement disorders : official journal of the Movement Disorder Society 2004;19(12):1409-13.
2004: Hauser Robert A; Lyons Kelly E
Future therapies for Parkinson's disease.
Neurologic clinics 2004;22(3 Suppl):S149-66.
2004: Zesiewicz T A; Strom J A; Borenstein A R; Hauser R A; Cimino C R; Fontanet H L; Cintron G B; Staffetti J F; Dunne P B; Sullivan K L
Heart failure in Parkinson's disease: analysis of the United States medicare current beneficiary survey.
Parkinsonism & related disorders 2004;10(7):417-20.
2004: Sullivan Kelly L; Hauser Robert A; Zesiewicz Theresa A
Essential tremor. Epidemiology, diagnosis, and treatment.
The neurologist 2004;10(5):250-8.
2004: Zesiewicz Theresa A; Stamey William; Sullivan Kelly L; Hauser Robert A
Botulinum toxin A for the treatment of cervical dystonia.
Expert opinion on pharmacotherapy 2004;5(9):2017-24.
2004: Stern Matthew B; Marek Kenneth L; Friedman Joseph; Hauser Robert A; LeWitt Peter A; Tarsy Daniel; Olanow C Warren
Double-blind, randomized, controlled trial of rasagiline as monotherapy in early Parkinson's disease patients.
Movement disorders : official journal of the Movement Disorder Society 2004;19(8):916-23.
2004: Pahwa Rajesh; Lyons Kelly E; Hauser Robert A
Ropinirole therapy for Parkinson's disease.
Expert review of neurotherapeutics 2004;4(4):581-8.
2004: Adler C H; Hauser R A; Sethi K; Caviness J N; Marlor L; Anderson W M; Hentz J G
Ropinirole for restless legs syndrome: a placebo-controlled crossover trial.
Neurology 2004;62(8):1405-7.
2004: Waters Cheryl H; Sethi Kapil D; Hauser Robert A; Molho Eric; Bertoni John M;
Zydis selegiline reduces off time in Parkinson's disease patients with motor fluctuations: a 3-month, randomized, placebo-controlled study.
Movement disorders : official journal of the Movement Disorder Society 2004;19(4):426-32.
2004: Hauser Robert A
Levodopa/carbidopa/entacapone (Stalevo).
Neurology 2004;62(1 Suppl 1):S64-71.
2003: Kase Hiroshi; Aoyama S; Ichimura M; Ikeda K; Ishii A; Kanda T; Koga K; Koike N; Kurokawa M; Kuwana Y; Mori A; Nakamura J; Nonaka H; Ochi M; Saki M; Shimada J; Shindou T; Shiozaki S; Suzuki F; Takeda M; Yanagawa K; Richardson P J; Jenner P; Bedard P; Borrelli E; Hauser R A; Chase T N;
Progress in pursuit of therapeutic A2A antagonists: the adenosine A2A receptor selective antagonist KW6002: research and development toward a novel nondopaminergic therapy for Parkinson's disease.
Neurology 2003;61(11 Suppl 6):S97-100.
2003: Hauser Robert A; Hubble Jean P; Truong Daniel D;
Randomized trial of the adenosine A(2A) receptor antagonist istradefylline in advanced PD.
Neurology 2003;61(3):297-303.
2003: Whone Alan L; Watts Ray L; Stoessl A Jon; Davis Margaret; Reske Sven; Nahmias Claude; Lang Anthony E; Rascol Olivier; Ribeiro Maria J; Remy Philippe; Poewe Werner H; Hauser Robert A; Brooks David J;
Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.
Annals of neurology 2003;54(1):93-101.
2003: Crawford Fiona C; Ait-Ghezala Ghania; Morris Mark; Sutcliffe Maxine J; Hauser Robert A; Silver Archie A; Mullan Michael J
Translocation breakpoint in two unrelated Tourette syndrome cases, within a region previously linked to the disorder.
Human genetics 2003;113(2):154-61.
2003: Zesiewicz Theresa A; Hauser Robert A
Sleep attacks and dopamine agonists for Parkinson's disease: what is currently known?
CNS drugs 2003;17(8):593-600.
2002: Zesiewicz T A; Cimino C R; Malek A R; Gardner N; Leaverton P L; Dunne P B; Hauser R A
Driving safety in Parkinson's disease.
Neurology 2002;59(11):1787-8.
2002: Zesiewicz Theresa A; Borra Sujatha; Hauser Robert A
Clozapine withdrawal symptoms in a Parkinson's disease patient.
Movement disorders : official journal of the Movement Disorder Society 2002;17(6):1365-7.
2002: Hauser Robert A; Holford Nicholas H G
Quantitative description of loss of clinical benefit following withdrawal of levodopa-carbidopa and bromocriptine in early Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2002;17(5):961-8.
2002: Zesiewicz Theresa A; Encarnacion Elmyra; Hauser Robert A
Management of essential tremor.
Current neurology and neuroscience reports 2002;2(4):324-30.
2002: Hauser Robert A; Sandberg Paul R; Freeman Thomas B; Stoessl A John
Bilateral human fetal striatal transplantation in Huntington's disease.
Neurology 2002;58(11):1704; author reply 1704.
2002: Hauser R A; Furtado S; Cimino C R; Delgado H; Eichler S; Schwartz S; Scott D; Nauert G M; Soety E; Sossi V; Holt D A; Sanberg P R; Stoessl A J; Freeman T B
Bilateral human fetal striatal transplantation in Huntington's disease.
Neurology 2002;58(5):687-95.
2002: Zesiewicz Theresa A; Hauser Robert A
Depression in Parkinson's disease.
Current psychiatry reports 2002;4(1):69-73.
2001: Zesiewicz T A; Hauser R A
Phenomenology and treatment of tremor disorders.
Neurologic clinics 2001;19(3):651-80, vii.
2001: Shoulson I; Penney J; McDermott M; Schwid S; Kayson E; Chase T; Fahn S; Greenamyre J T; Lang A; Siderowf A; Pearson N; Harrison M; Rost E; Colcher A; Lloyd M; Matthews M; Pahwa R; McGuire D; Lew M F; Schuman S; Marek K; Broshjeit S; Factor S; Brown D; Feigin A; Mazurkiewicz J; Ford B; Jennings D; Dilllon S; Comella C; Blasucci L; Janko K; Shulman L; Wiener W; Bateman-Rodriguez D; Carrion A; Suchowersky O; Lafontaine A L; Pantella C; Siemers E; Belden J; Davies R; Lannon M; Grimes D; Gray P; Martin W; Kennedy L; Adler C; Newman S; Hammerstad J; Stone C; Lewitt P; Bardram K; Mistura K; Miyasaki J; Johnston L; Cha J H; Tennis M; Panniset M; Hall J; Tetrud J; Friedlander J; Hauser R; Gauger L; Rodnitzky R; Deleo A; Dobson J; Seeberger L; Dingmann C; Tarsy D; Ryan P; Elmer L; Ruzicka D; Stacy M; Brewer M; Locke B; Baker D; Casaceli C; Day D; Florack M; Hodgeman K; Laroia N; Nobel R; Orme C; Rexo L; Rothenburgh K; Sulimowicz K; Watts A; Wratni E; Tariot P; Cox C; Leventhal C; Alderfer V; Craun A M; Frey J; McCree L; McDermott J; Cooper J; Holdich T; Read B;
A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease.
Neurology 2001;56(4):455-62.
2001: Freeman T B; Willing A; Zigova T; Sanberg P R; Hauser R A
Neural transplantation in Parkinson's disease.
Advances in neurology 2001;86():435-45.
2001: Zesiewicz T A; Hauser R A
Neurosurgery for Parkinson's disease.
Seminars in neurology 2001;21(1):91-101.
2000: Freeman T B; Cicchetti F; Hauser R A; Deacon T W; Li X J; Hersch S M; Nauert G M; Sanberg P R; Kordower J H; Saporta S; Isacson O
Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(25):13877-82.
2000: Hauser R A; Wahba M N; Zesiewicz T A; McDowell Anderson W
Modafinil treatment of pramipexole-associated somnolence.
Movement disorders : official journal of the Movement Disorder Society 2000;15(6):1269-71.
2000: Hauser R A; Friedlander J; Baker M J; Thomas J; Zuckerman K S
Adult Chediak-Higashi parkinsonian syndrome with dystonia.
Movement disorders : official journal of the Movement Disorder Society 2000;15(4):705-8.
2000: Hauser R A; Gauger L; Anderson W M; Zesiewicz T A
Pramipexole-induced somnolence and episodes of daytime sleep.
Movement disorders : official journal of the Movement Disorder Society 2000;15(4):658-63.
2000: Hauser R A; Koller W C; Hubble J P; Malapira T; Busenbark K; Olanow C W
Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease.
Movement disorders : official journal of the Movement Disorder Society 2000;15(3):485-9.
2000: Hauser R A; Friedlander J; Zesiewicz T A; Adler C H; Seeberger L C; O'Brien C F; Molho E S; Factor S A
A home diary to assess functional status in patients with Parkinson's disease with motor fluctuations and dyskinesia.
Clinical neuropharmacology 2000;23(2):75-81.
2000: Zesiewicz T A; Helal M; Hauser R A
Sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2000;15(2):305-8.
2000: Freeman T B; Hauser R A; Sanberg P R; Saporta S
Neural transplantation for the treatment of Huntington's disease.
Progress in brain research 2000;127():405-11.
2000: Freeman T B; Hauser R A; Willing A E; Zigova T; Sanberg P R; Saporta S
Transplantation of human fetal striatal tissue in Huntington's disease: rationale for clinical studies.
Novartis Foundation symposium 2000;231():129-38; discussion 139-47.
1999: Freeman T B; Vawter D E; Leaverton P E; Godbold J H; Hauser R A; Goetz C G; Olanow C W
Use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson's disease.
The New England journal of medicine 1999;341(13):988-92.
1999: Freeman T B; Hauser R A; Sanberg P R
Fatal transplant cyst.
Journal of neurosurgery 1999;90(6):1148-50.
1999: Zesiewicz T A; Hauser R A
Ropinirole in the treatment of Parkinson's disease.
Expert opinion on investigational drugs 1999;8(5):697-710.
1999: Hauser R A; Zesiewicz T A
Management of early Parkinson's disease.
The Medical clinics of North America 1999;83(2):393-414, vi.
1999: Hauser R A
Punishing the pain. Treating chronic pain with prolotherapy.
Rehab management 1999;12(2):26-8, 30.
1999: Hauser R A; Freeman T B; Snow B J; Nauert M; Gauger L; Kordower J H; Olanow C W
Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease.
Archives of neurology 1999;56(2):179-87.
1999: Zesiewicz T A; Gold M; Chari G; Hauser R A
Current issues in depression in Parkinson's disease.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 1999;7(2):110-8.
1998: Hauser R A; Malek A R; Rosen R
Successful treatment of a patient with severe refractory myasthenia gravis using mycophenolate mofetil.
Neurology 1998;51(3):912-3.
1998: Sethi K D; O'Brien C F; Hammerstad J P; Adler C H; Davis T L; Taylor R L; Sanchez-Ramos J; Bertoni J M; Hauser R A
Ropinirole for the treatment of early Parkinson disease: a 12-month experience. Ropinirole Study Group.
Archives of neurology 1998;55(9):1211-6.
1998: Adler C H; Singer C; O'Brien C; Hauser R A; Lew M F; Marek K L; Dorflinger E; Pedder S; Deptula D; Yoo K
Randomized, placebo-controlled study of tolcapone in patients with fluctuating Parkinson disease treated with levodopa-carbidopa. Tolcapone Fluctuator Study Group III.
Archives of neurology 1998;55(8):1089-95.
1998: Hauser R A; Molho E; Shale H; Pedder S; Dorflinger E E
A pilot evaluation of the tolerability, safety, and efficacy of tolcapone alone and in combination with oral selegiline in untreated Parkinson's disease patients. Tolcapone De Novo Study Group.
Movement disorders : official journal of the Movement Disorder Society 1998;13(4):643-7.
1998: Kompoliti K; Goetz C G; Boeve B F; Maraganore D M; Ahlskog J E; Marsden C D; Bhatia K P; Greene P E; Przedborski S; Seal E C; Burns R S; Hauser R A; Gauger L L; Factor S A; Molho E S; Riley D E
Clinical presentation and pharmacological therapy in corticobasal degeneration.
Archives of neurology 1998;55(7):957-61.
1998: Kordower J H; Freeman T B; Chen E Y; Mufson E J; Sanberg P R; Hauser R A; Snow B; Olanow C W
Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1998;13(3):383-93.
1998: Hauser R A; Friedlander J; Smith D A; Nolan M F
Delayed stimulation-induced thalamic ataxia syndrome.
Neurology 1998;50(4):1184-5.
1998: Gold M; Hauser R A; Chen M F
Plasma thiamine deficiency associated with Alzheimer's disease but not Parkinson's disease.
Metabolic brain disease 1998;13(1):43-53.
1997: Holt D A; Nauert G M; Othberg A I; Randall T S; Willing A E; Widen R H; Hauser R A; Sanberg P R; Olanow C W; Freeman T B
Infectious issues in human fetal neural transplantation.
Cell transplantation 1997;6(6):553-6.
1997: Hauser R A; Zesiewicz T A
Sertraline for the treatment of depression in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1997;12(5):756-9.
1997: Koller W; Pahwa R; Busenbark K; Hubble J; Wilkinson S; Lang A; Tuite P; Sime E; Lazano A; Hauser R; Malapira T; Smith D; Tarsy D; Miyawaki E; Norregaard T; Kormos T; Olanow C W
High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor.
Annals of neurology 1997;42(3):292-9.
1997: Borlongan C V; Koutouzis T K; Freeman T B; Hauser R A; Cahill D W; Sanberg P R
Hyperactivity and hypoactivity in a rat model of Huntington's disease: the systemic 3-nitropropionic acid model.
Brain research. Brain research protocols 1997;1(3):253-7.
1997: Adler C H; Sethi K D; Hauser R A; Davis T L; Hammerstad J P; Bertoni J; Taylor R L; Sanchez-Ramos J; O'Brien C F
Ropinirole for the treatment of early Parkinson's disease. The Ropinirole Study Group.
Neurology 1997;49(2):393-9.
1997: Freeman T B; Vawter D; Goetz C G; Leaverton P E; Hauser R A; Sanberg P R; Godbold J H; Olanow C W
Toward the use of surgical placebo-controlled trials.
Transplantation proceedings 1997;29(4):1925.
1997: Hauser R A; Zesiewicz T A; Factor S A; Guttman M; Weiner W J
Clinical trials of add-on medications in Parkinson's disease: Efficacy versus usefulness.
Parkinsonism & related disorders 1997;3(1):1-6.
1996: Hauser R A; Murtaugh F R; Akhter K; Gold M; Olanow C W
Magnetic resonance imaging of corticobasal degeneration.
Journal of neuroimaging : official journal of the American Society of Neuroimaging 1996;6(4):222-6.
1996: Borlongan C V; Freeman T B; Hauser R A; Cahill D W; Sanberg P R
Cyclosporine-A increases locomotor activity in rats with 6-hydroxydopamine-induced hemiparkinsonism: relevance to neural transplantation.
Surgical neurology 1996;46(4):384-8.
1996: Hauser R A; Zesiewicz T A
Manganese and chronic liver disease.
Movement disorders : official journal of the Movement Disorder Society 1996;11(5):589.
1996: Borlongan C V; Polgar S; Freeman T B; Hauser R A; Cahill D W; Sanberg P R
Will fetal striatal transplants correct the akinetic end-stage of Huntington's disease?
Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration 1996;5(2):189-92.
1996: Hauser R A; Zesiewicz T A; Martinez C; Rosemurgy A S; Olanow C W
Blood manganese correlates with brain magnetic resonance imaging changes in patients with liver disease.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1996;23(2):95-8.
1995: Olanow C W; Hauser R A; Gauger L; Malapira T; Koller W; Hubble J; Bushenbark K; Lilienfeld D; Esterlitz J
The effect of deprenyl and levodopa on the progression of Parkinson's disease.
Annals of neurology 1995;38(5):771-7.
1995: Hauser R A; Zesiewicz T A
Sertraline-induced exacerbation of tics in Tourette's syndrome.
Movement disorders : official journal of the Movement Disorder Society 1995;10(5):682-4.
1995: Freeman T B; Olanow C W; Hauser R A; Nauert G M; Smith D A; Borlongan C V; Sanberg P R; Holt D A; Kordower J H; Vingerhoets F J
Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease.
Annals of neurology 1995;38(3):379-88.
1995: Kordower J H; Freeman T B; Snow B J; Vingerhoets F J; Mufson E J; Sanberg P R; Hauser R A; Smith D A; Nauert G M; Perl D P
Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease.
The New England journal of medicine 1995;332(17):1118-24.
1994: Hauser R A; Zesiewicz T A; Rosemurgy A S; Martinez C; Olanow C W
Manganese intoxication and chronic liver failure.
Annals of neurology 1994;36(6):871-5.
1994: Hauser R A; Olanow C W
Magnetic resonance imaging of neurodegenerative diseases.
Journal of neuroimaging : official journal of the American Society of Neuroimaging 1994;4(3):146-58.
1994: Hauser R A; Trehan R
Initial experience with electroconvulsive therapy for progressive supranuclear palsy.
Movement disorders : official journal of the Movement Disorder Society 1994;9(4):467-9.
1994: Griffin D K; Shriver M E; Hauser R
Parinaud's syndrome as the initial manifestation of acquired immunodeficiency syndrome.
Journal of neuroimaging : official journal of the American Society of Neuroimaging 1994;4(2):113-4.
1993: Hauser R A; Olanow C W
Orobuccal dyskinesia associated with trihexyphenidyl therapy in a patient with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1993;8(4):512-4.
1993: Woodward W R; Olanow C W; Beckner R M; Hauser R A; Gauger L L; Cedarbaum J M; Nutt J G
The effect of L-dopa infusions with and without phenylalanine challenges in parkinsonian patients: plasma and ventricular CSF L-dopa levels and clinical responses.
Neurology 1993;43(9):1704-8.
1991: Hauser R A; Olanow C W
Early therapy for Parkinson's disease.
Archives of neurology 1991;48(10):1009-10.
1988: Hauser R A; Lacey D M; Knight M R
Hypertensive encephalopathy. Magnetic resonance imaging demonstration of reversible cortical and white matter lesions.
Archives of neurology 1988;45(10):1078-83.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Robert Hauser

Research Profile (preview)

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Robert Hauser (preview)

All Publications